Clinical Trial Update: Methylphenidate HCl or Modafinil in Treating Young Patients With Excessive Daytime Sleepiness After Cancer Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated methylphenidate HCl or modafinil for excessive daytime sleepiness in young patients after cancer therapy. The study was termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Tumors
• Sleep Disorders

Drugs mentioned

• Methylphenidate HCl (Methylphenidate hydrochloride)
• Modafinil (modafinil)

Snippet

Sponsor: University of South Florida | Conditions: Central Nervous System Tumor, Pediatric, Fatigue | Phase 2 | Status: TERMINATED | Results posted: 2013-09-19